Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691-697.
Autor: | Kiri V; V&JK Consulting Limited - Pharmacoepidemiology, Guildford, United Kingdom of Great Britain and Northern Ireland., MacKenzie G; Department of Mathematics & Statistics, University of Limerick, Limerick, Ireland. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of medical economics [J Med Econ] 2021 Jan-Dec; Vol. 24 (1), pp. 862-863. |
DOI: | 10.1080/13696998.2021.1948732 |
Databáze: | MEDLINE |
Externí odkaz: |